Loading
Almost no surgeons or radiation oncologists have time or funding to do research. Dedicated training awards with protected time would build the workforce that surgical and radiotherapy trials need.
A funded career pathway: integrated research years within surgical and radiation oncology training, career-development awards on the model of NIH K08/K23 but reserved for these specialties, protected time in the first faculty years and mentorship networks linked to the surgical and radiotherapy trials infrastructure. Surgeon-scientists are a shrinking fraction of NIH-funded investigators, and radiation oncology, though research-rich relative to its size, lacks trialists and translational scientists. Awards prioritise trial methodology, health services research and technology evaluation, the skills these fields lack most.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Not enough oncologists, nurses, pathologists, physicists.
Shares Hospital-funded protected time for clinician-scientists, repaid by trial revenue, Two-year translational fellowships that pay scientists to develop their own discovery.
Shares American Society of Clinical Oncology (ASCO), Not enough oncologists, nurses, pathologists, physicists.
Shares Michael Baumann, Surgery and radiotherapy cure most, get least.
Shares Not enough oncologists, nurses, pathologists, physicists, Surgery and radiotherapy cure most, get least.
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).
Shares European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO).